Stocks including Kotak Mahindra Bank, RITES, IndusInd Bank, IDFC First Bank, Dr Reddy's Labs, CDSL, Bank of Baroda, SAIL and ...

Sun Pharma, Lupin, and Dr Reddy's are recalling various drugs from the US market due to manufacturing issues and product mix-ups, as per the USFDA.

Top pharma players Dr Reddy, Lupin, and Sun Pharma are reportedly recalling drugs from the US market as a result of manufacturing faults an product mix up, as per the US Food and Drug Administration ...

Indian pharmaceutical companies Sun Pharma, Lupin, and Dr Reddy's Laboratories are conducting recalls in the US due to ...

With Indians consuming salt far in excess of the WHO-mandated limit of 5 gm a day, epidemiologists, researchers and food ...

Hyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an ...

Dr. Reddy's Laboratories Ltd. closed 10.04% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.

Dr. Reddy's Laboratories has kicked off FY26 with double-digit growth. M.V. Ramana, CEO of Branded Markets (India & Emerging ...

Dr Reddy's Laboratories share price gained almost 3% in the morning trades on Thursday post Q1 results that were declared ...

In a decisive move against what it viewed as an unjustified price escalation, the Multi-Disciplinary Committee (MDC) under ...

Emkay Global has raised Dr Reddy’s target price to ₹1,150 from ₹1,050 but maintained a ‘Reduce’ rating after a weak Q1FY26 ...

Erez Israeli, CEO of Dr Reddys Laboratories, said that the company has no plans to shift manufacturing to the US unless it ...